Olson, Richard
Bristol-Myers Squibb (United States)
3 papers on CoChatORCID 0000-0001-5471-1404
Most cited papers
- Verified
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 401
- Verified
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
Bristow, L. J., Easton, A. E., Li, Y.-W., Sivarao, D. V., Lidge, R., Jones, K. M., Post-Munson, D., Daly, C., Lodge, N. J., Gallagher, L., et al. (2016) · PLOS ONE
Nicotinic Acetylcholine Receptors StudySchizophrenia research and treatment
Cited by 30
- Verified
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning
Weed, M. R., Polino, J., Signor, L., Bookbinder, M., Keavy, D., Benitex, Y., Morgan, D. G., King, D., Macor, J. E., Zaczek, R., et al. (2017) · PLOS ONE
Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free